Victor Gabriel Sanchez
Ahead of the annual global bio convention, Victor Sanchez explains the opportunity for Mexico in this growing industry.
Amyloid transthyretin polyneuropathy is a rare and fatal disease that can affect up to 40,000 people worldwide, said AstraZeneca’s Mene Pangalos.
President & CEO
Optimizing the pharma business model by offering e-commerce options in this digital era is simply smart business, writes Sandra Sánchez-Oldenhage.
Researchers highlight that a delayed second dose of the AstraZeneca vaccine enhances immune response, which could be beneficial for Mexico.